Thomas Anchordoquy
Concepts (322)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liposomes | 25 | 2023 | 146 | 5.590 |
Why?
| DNA | 30 | 2018 | 1350 | 4.040 |
Why?
| Gene Transfer Techniques | 12 | 2021 | 147 | 3.260 |
Why?
| Nanoparticles | 9 | 2021 | 312 | 3.090 |
Why?
| Cholesterol | 13 | 2019 | 368 | 2.860 |
Why?
| Lipids | 19 | 2016 | 564 | 2.770 |
Why?
| Freeze Drying | 18 | 2014 | 74 | 2.380 |
Why?
| Transfection | 20 | 2021 | 863 | 2.200 |
Why?
| Neoplasms | 12 | 2023 | 2086 | 2.180 |
Why?
| Plasmids | 17 | 2021 | 343 | 2.170 |
Why?
| Polyethylene Glycols | 9 | 2020 | 561 | 2.140 |
Why?
| Drug Carriers | 8 | 2019 | 112 | 2.100 |
Why?
| Exosomes | 5 | 2018 | 92 | 1.660 |
Why?
| Quaternary Ammonium Compounds | 12 | 2014 | 44 | 1.340 |
Why?
| Particle Size | 17 | 2021 | 317 | 1.290 |
Why?
| Fatty Acids, Monounsaturated | 11 | 2014 | 47 | 1.250 |
Why?
| Nucleic Acids | 3 | 2015 | 59 | 1.230 |
Why?
| Drug Delivery Systems | 6 | 2023 | 295 | 1.210 |
Why?
| Polymers | 4 | 2021 | 448 | 1.080 |
Why?
| Nanomedicine | 3 | 2023 | 28 | 1.020 |
Why?
| Phosphatidylcholines | 5 | 2014 | 132 | 0.840 |
Why?
| Cell Line, Tumor | 13 | 2019 | 2698 | 0.780 |
Why?
| Chemistry, Pharmaceutical | 9 | 2014 | 98 | 0.760 |
Why?
| Receptor, ErbB-2 | 2 | 2014 | 300 | 0.730 |
Why?
| Animals | 38 | 2021 | 31565 | 0.730 |
Why?
| DNA, Superhelical | 2 | 2011 | 11 | 0.690 |
Why?
| Drug Stability | 11 | 2020 | 151 | 0.690 |
Why?
| Genetic Vectors | 5 | 2006 | 287 | 0.670 |
Why?
| Tissue Distribution | 5 | 2021 | 285 | 0.670 |
Why?
| COS Cells | 11 | 2009 | 175 | 0.640 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2019 | 12 | 0.640 |
Why?
| Cytokines | 3 | 2021 | 1824 | 0.620 |
Why?
| Receptors, Fc | 1 | 2018 | 45 | 0.610 |
Why?
| Mice, Inbred BALB C | 6 | 2018 | 1144 | 0.610 |
Why?
| Carbohydrates | 4 | 2014 | 55 | 0.590 |
Why?
| DNA, Circular | 2 | 2011 | 13 | 0.590 |
Why?
| Milk | 1 | 2018 | 123 | 0.590 |
Why?
| Histocompatibility Antigens Class I | 1 | 2018 | 170 | 0.570 |
Why?
| Blood Proteins | 3 | 2015 | 222 | 0.570 |
Why?
| Drug Storage | 3 | 2020 | 57 | 0.570 |
Why?
| Oligopeptides | 1 | 2019 | 234 | 0.560 |
Why?
| Leukocytes | 1 | 2018 | 272 | 0.550 |
Why?
| Immunocompetence | 1 | 2016 | 40 | 0.550 |
Why?
| Scattering, Radiation | 5 | 2010 | 94 | 0.520 |
Why?
| Hemolysin Proteins | 2 | 2014 | 31 | 0.510 |
Why?
| Mice | 15 | 2021 | 14841 | 0.510 |
Why?
| Freezing | 6 | 2014 | 84 | 0.500 |
Why?
| Spermine | 2 | 2006 | 26 | 0.500 |
Why?
| Bacterial Toxins | 2 | 2014 | 103 | 0.490 |
Why?
| Heat-Shock Proteins | 2 | 2014 | 112 | 0.490 |
Why?
| Granulocytes | 1 | 2015 | 75 | 0.490 |
Why?
| Sphingosine | 1 | 2014 | 33 | 0.470 |
Why?
| Phosphatidylethanolamines | 7 | 2014 | 66 | 0.470 |
Why?
| Alkynes | 1 | 2014 | 53 | 0.460 |
Why?
| Azides | 1 | 2014 | 46 | 0.460 |
Why?
| Click Chemistry | 1 | 2014 | 48 | 0.450 |
Why?
| Complement C3 | 1 | 2015 | 188 | 0.450 |
Why?
| Intestinal Mucosa | 1 | 2018 | 532 | 0.450 |
Why?
| Folic Acid | 2 | 2012 | 161 | 0.440 |
Why?
| Calorimetry, Differential Scanning | 6 | 2013 | 34 | 0.440 |
Why?
| Ferrous Compounds | 1 | 2013 | 22 | 0.430 |
Why?
| Microspheres | 2 | 2011 | 123 | 0.420 |
Why?
| Water | 3 | 2011 | 394 | 0.420 |
Why?
| Antineoplastic Agents | 4 | 2018 | 1875 | 0.410 |
Why?
| Trace Elements | 1 | 2013 | 45 | 0.410 |
Why?
| Surface Properties | 5 | 2017 | 385 | 0.400 |
Why?
| Metals | 1 | 2013 | 105 | 0.400 |
Why?
| Cations | 6 | 2014 | 77 | 0.380 |
Why?
| Phospholipids | 1 | 2013 | 194 | 0.380 |
Why?
| Reactive Oxygen Species | 3 | 2008 | 523 | 0.380 |
Why?
| Luciferases | 4 | 2017 | 142 | 0.370 |
Why?
| Surface-Active Agents | 2 | 2009 | 79 | 0.360 |
Why?
| Bleomycin | 1 | 2012 | 228 | 0.360 |
Why?
| Biological Therapy | 1 | 2011 | 26 | 0.360 |
Why?
| Gold | 1 | 2011 | 102 | 0.350 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2011 | 465 | 0.340 |
Why?
| Genetic Therapy | 6 | 2014 | 256 | 0.330 |
Why?
| L-Lactate Dehydrogenase | 3 | 2002 | 107 | 0.330 |
Why?
| Models, Chemical | 1 | 2011 | 248 | 0.330 |
Why?
| Cell Membrane | 1 | 2013 | 670 | 0.330 |
Why?
| Disease Models, Animal | 3 | 2021 | 3498 | 0.320 |
Why?
| MCF-7 Cells | 3 | 2014 | 105 | 0.320 |
Why?
| Fluorescent Dyes | 4 | 2018 | 298 | 0.320 |
Why?
| Liver | 2 | 2015 | 1633 | 0.310 |
Why?
| Trehalose | 4 | 2014 | 30 | 0.300 |
Why?
| Humans | 31 | 2023 | 114043 | 0.290 |
Why?
| Nucleic Acid Conformation | 6 | 2009 | 670 | 0.280 |
Why?
| Biological Availability | 2 | 2018 | 119 | 0.280 |
Why?
| Mice, Nude | 3 | 2017 | 628 | 0.280 |
Why?
| Cell Line | 4 | 2014 | 2629 | 0.270 |
Why?
| Endosomes | 2 | 2021 | 122 | 0.270 |
Why?
| Ferric Compounds | 1 | 2006 | 41 | 0.270 |
Why?
| Polydeoxyribonucleotides | 1 | 2006 | 12 | 0.260 |
Why?
| Gene Expression Regulation | 1 | 2014 | 2321 | 0.250 |
Why?
| Extracellular Vesicles | 2 | 2018 | 83 | 0.250 |
Why?
| Cattle | 3 | 2018 | 918 | 0.250 |
Why?
| Spermidine | 1 | 2005 | 16 | 0.240 |
Why?
| Dextrans | 1 | 2005 | 73 | 0.240 |
Why?
| Breast Neoplasms | 2 | 2014 | 1846 | 0.230 |
Why?
| Genes, Reporter | 2 | 2017 | 256 | 0.230 |
Why?
| Polyesters | 1 | 2004 | 64 | 0.230 |
Why?
| Sucrose | 4 | 2013 | 92 | 0.230 |
Why?
| Ligands | 2 | 2019 | 557 | 0.220 |
Why?
| Osmolar Concentration | 3 | 2013 | 169 | 0.220 |
Why?
| Doxorubicin | 2 | 2014 | 286 | 0.210 |
Why?
| Carbocyanines | 2 | 2018 | 30 | 0.210 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2013 | 134 | 0.210 |
Why?
| Glioma | 2 | 2016 | 285 | 0.210 |
Why?
| Adsorption | 2 | 2013 | 120 | 0.200 |
Why?
| Lupus Nephritis | 1 | 2021 | 52 | 0.180 |
Why?
| Vaccine Potency | 1 | 2020 | 6 | 0.180 |
Why?
| Excipients | 3 | 2008 | 49 | 0.180 |
Why?
| Vaccines, Synthetic | 1 | 2020 | 124 | 0.170 |
Why?
| Polyethyleneimine | 3 | 2013 | 18 | 0.170 |
Why?
| Lactose | 1 | 2020 | 6 | 0.170 |
Why?
| Theranostic Nanomedicine | 1 | 2020 | 8 | 0.170 |
Why?
| RNA, Small Interfering | 2 | 2013 | 534 | 0.170 |
Why?
| Temperature | 2 | 2013 | 564 | 0.170 |
Why?
| Flow Cytometry | 2 | 2014 | 1075 | 0.160 |
Why?
| Nanotechnology | 1 | 2020 | 113 | 0.160 |
Why?
| Toxicity Tests | 1 | 2019 | 28 | 0.160 |
Why?
| Thiobarbituric Acid Reactive Substances | 2 | 2008 | 20 | 0.160 |
Why?
| Oligonucleotides | 2 | 2011 | 137 | 0.150 |
Why?
| Permeability | 1 | 2018 | 149 | 0.150 |
Why?
| Solubility | 1 | 2018 | 223 | 0.150 |
Why?
| Pentetic Acid | 2 | 2008 | 12 | 0.150 |
Why?
| Female | 8 | 2021 | 59325 | 0.150 |
Why?
| beta-Galactosidase | 1 | 1997 | 62 | 0.150 |
Why?
| Chelating Agents | 2 | 2008 | 61 | 0.150 |
Why?
| Immunity, Innate | 1 | 2023 | 720 | 0.140 |
Why?
| Mice, SCID | 1 | 2018 | 312 | 0.140 |
Why?
| Drug Liberation | 1 | 2017 | 25 | 0.140 |
Why?
| Electrophoresis, Agar Gel | 2 | 2008 | 25 | 0.140 |
Why?
| Drug Compounding | 1 | 2017 | 89 | 0.140 |
Why?
| Neoplasm Transplantation | 1 | 2017 | 227 | 0.130 |
Why?
| Administration, Oral | 1 | 2018 | 725 | 0.130 |
Why?
| Astrocytes | 1 | 2018 | 159 | 0.130 |
Why?
| Cell Survival | 3 | 2014 | 1014 | 0.130 |
Why?
| Tumor Burden | 1 | 2017 | 258 | 0.130 |
Why?
| Proteins | 2 | 2017 | 906 | 0.130 |
Why?
| Ions | 1 | 2015 | 59 | 0.130 |
Why?
| Nebulizers and Vaporizers | 2 | 2006 | 77 | 0.130 |
Why?
| Glioblastoma | 1 | 2018 | 250 | 0.120 |
Why?
| Kinetics | 3 | 2005 | 1547 | 0.120 |
Why?
| Circular Dichroism | 2 | 2006 | 135 | 0.120 |
Why?
| Alanine Transaminase | 1 | 2015 | 141 | 0.120 |
Why?
| DNA Damage | 2 | 2008 | 351 | 0.120 |
Why?
| Pharmaceutical Vehicles | 1 | 2014 | 11 | 0.120 |
Why?
| Time Factors | 4 | 2014 | 6077 | 0.120 |
Why?
| Tumor Microenvironment | 1 | 2018 | 428 | 0.120 |
Why?
| Glycerylphosphorylcholine | 1 | 2014 | 5 | 0.120 |
Why?
| Buffers | 2 | 2013 | 53 | 0.120 |
Why?
| Transition Temperature | 1 | 2014 | 26 | 0.120 |
Why?
| Urate Oxidase | 1 | 2014 | 9 | 0.120 |
Why?
| Nephelometry and Turbidimetry | 2 | 2004 | 15 | 0.120 |
Why?
| Drug Administration Schedule | 1 | 2016 | 714 | 0.120 |
Why?
| Cycloaddition Reaction | 1 | 2014 | 24 | 0.120 |
Why?
| Molecular Weight | 2 | 2005 | 328 | 0.120 |
Why?
| Asparaginase | 1 | 2014 | 29 | 0.120 |
Why?
| Injections, Intravenous | 1 | 2014 | 198 | 0.120 |
Why?
| Neoplasms, Experimental | 1 | 2015 | 149 | 0.110 |
Why?
| Contrast Media | 1 | 2017 | 347 | 0.110 |
Why?
| Polylysine | 1 | 2014 | 17 | 0.110 |
Why?
| Antibiotics, Antineoplastic | 1 | 2014 | 110 | 0.110 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 347 | 0.110 |
Why?
| Hydrophobic and Hydrophilic Interactions | 2 | 2005 | 176 | 0.110 |
Why?
| Choline | 1 | 2014 | 106 | 0.110 |
Why?
| Copper | 1 | 2014 | 99 | 0.110 |
Why?
| Cross-Linking Reagents | 1 | 2014 | 179 | 0.110 |
Why?
| Dendrimers | 1 | 2013 | 13 | 0.110 |
Why?
| Immune Tolerance | 1 | 2015 | 321 | 0.110 |
Why?
| Sulfites | 1 | 2013 | 4 | 0.110 |
Why?
| Neoplasm Proteins | 1 | 2016 | 385 | 0.110 |
Why?
| Cell Proliferation | 2 | 2018 | 2173 | 0.110 |
Why?
| Drug Contamination | 1 | 2013 | 51 | 0.110 |
Why?
| Leukocytes, Mononuclear | 1 | 2015 | 489 | 0.100 |
Why?
| Antibodies | 1 | 2014 | 365 | 0.100 |
Why?
| Viruses | 1 | 2013 | 94 | 0.100 |
Why?
| Fluoresceins | 1 | 2012 | 46 | 0.100 |
Why?
| KB Cells | 1 | 2012 | 4 | 0.100 |
Why?
| Luciferases, Firefly | 1 | 2012 | 3 | 0.100 |
Why?
| Fluorescence Resonance Energy Transfer | 2 | 2004 | 167 | 0.100 |
Why?
| Binding Sites | 2 | 2006 | 1166 | 0.100 |
Why?
| Sonication | 1 | 2011 | 10 | 0.100 |
Why?
| Trastuzumab | 1 | 2012 | 89 | 0.100 |
Why?
| Extracellular Space | 1 | 2012 | 116 | 0.100 |
Why?
| Hydrogen-Ion Concentration | 3 | 2005 | 507 | 0.100 |
Why?
| Cytoplasm | 1 | 2012 | 255 | 0.090 |
Why?
| Immunotherapy | 1 | 2015 | 473 | 0.090 |
Why?
| Hydrodynamics | 1 | 2011 | 36 | 0.090 |
Why?
| Thermodynamics | 2 | 2005 | 380 | 0.090 |
Why?
| Vaccines, DNA | 1 | 2011 | 29 | 0.090 |
Why?
| Proteomics | 2 | 2016 | 815 | 0.090 |
Why?
| Cerebellar Neoplasms | 1 | 2012 | 130 | 0.090 |
Why?
| Oligonucleotides, Antisense | 1 | 2011 | 100 | 0.090 |
Why?
| Medulloblastoma | 1 | 2012 | 172 | 0.090 |
Why?
| In Vitro Techniques | 3 | 2008 | 1003 | 0.090 |
Why?
| DNA, Bacterial | 1 | 2011 | 312 | 0.080 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2012 | 695 | 0.080 |
Why?
| Humidity | 1 | 2009 | 36 | 0.080 |
Why?
| Suspensions | 2 | 2008 | 30 | 0.080 |
Why?
| Peptides | 1 | 2014 | 848 | 0.080 |
Why?
| Stress, Mechanical | 1 | 2011 | 445 | 0.080 |
Why?
| Enzyme Stability | 2 | 2001 | 62 | 0.080 |
Why?
| Methods | 1 | 2008 | 57 | 0.080 |
Why?
| Mice, Knockout | 1 | 2015 | 2562 | 0.080 |
Why?
| alpha-Tocopherol | 1 | 2008 | 25 | 0.080 |
Why?
| Brain Neoplasms | 1 | 2016 | 966 | 0.080 |
Why?
| Energy Transfer | 1 | 2008 | 47 | 0.080 |
Why?
| Ethidium | 1 | 2008 | 5 | 0.080 |
Why?
| Gelatin | 1 | 2008 | 36 | 0.070 |
Why?
| Methionine | 1 | 2008 | 144 | 0.070 |
Why?
| Clozapine | 1 | 2008 | 19 | 0.070 |
Why?
| T-Lymphocytes | 1 | 2015 | 1735 | 0.070 |
Why?
| Luminescence | 1 | 2008 | 33 | 0.070 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 660 | 0.070 |
Why?
| Rabbits | 2 | 2001 | 733 | 0.070 |
Why?
| Protein Binding | 1 | 2013 | 1888 | 0.070 |
Why?
| Static Electricity | 2 | 2006 | 112 | 0.070 |
Why?
| Serum | 1 | 2008 | 57 | 0.070 |
Why?
| Escherichia coli | 1 | 2011 | 723 | 0.070 |
Why?
| Fluorescamine | 1 | 2006 | 1 | 0.070 |
Why?
| Phenanthrolines | 1 | 2006 | 7 | 0.070 |
Why?
| Deferoxamine | 1 | 2006 | 17 | 0.070 |
Why?
| Iron Chelating Agents | 1 | 2006 | 15 | 0.070 |
Why?
| Computer Simulation | 1 | 2011 | 873 | 0.070 |
Why?
| Edetic Acid | 1 | 2006 | 47 | 0.070 |
Why?
| Light | 2 | 2001 | 336 | 0.070 |
Why?
| Indicators and Reagents | 1 | 2006 | 99 | 0.070 |
Why?
| Iron | 1 | 2008 | 232 | 0.070 |
Why?
| Solutions | 1 | 2006 | 144 | 0.070 |
Why?
| Titrimetry | 1 | 2006 | 9 | 0.070 |
Why?
| Entropy | 1 | 2006 | 35 | 0.060 |
Why?
| Calorimetry | 1 | 2006 | 60 | 0.060 |
Why?
| Ultrasonics | 1 | 2006 | 46 | 0.060 |
Why?
| Antibodies, Monoclonal | 1 | 2012 | 1257 | 0.060 |
Why?
| Antipsychotic Agents | 1 | 2008 | 183 | 0.060 |
Why?
| Hydrogen Bonding | 1 | 2006 | 143 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 924 | 0.060 |
Why?
| Oxidation-Reduction | 1 | 2008 | 917 | 0.060 |
Why?
| Lung | 2 | 2015 | 3521 | 0.060 |
Why?
| Nucleic Acid Denaturation | 1 | 2005 | 31 | 0.060 |
Why?
| Aerosols | 1 | 2006 | 150 | 0.060 |
Why?
| Absorption | 1 | 2004 | 52 | 0.060 |
Why?
| Molecular Structure | 1 | 2006 | 434 | 0.060 |
Why?
| Behavior, Animal | 1 | 2008 | 459 | 0.060 |
Why?
| Microscopy, Electron, Scanning | 1 | 2004 | 192 | 0.060 |
Why?
| Pharmaceutical Preparations | 1 | 2006 | 164 | 0.060 |
Why?
| Schizophrenia | 1 | 2008 | 412 | 0.050 |
Why?
| Lactic Acid | 1 | 2004 | 272 | 0.050 |
Why?
| Sodium Chloride | 1 | 2003 | 133 | 0.050 |
Why?
| Shear Strength | 1 | 2002 | 65 | 0.050 |
Why?
| Base Sequence | 1 | 2006 | 2114 | 0.050 |
Why?
| Glycine | 1 | 2002 | 152 | 0.050 |
Why?
| Phosphates | 1 | 2002 | 155 | 0.050 |
Why?
| Sensitivity and Specificity | 1 | 2006 | 1690 | 0.050 |
Why?
| Imatinib Mesylate | 1 | 2021 | 63 | 0.050 |
Why?
| Salts | 1 | 2001 | 36 | 0.050 |
Why?
| Cell Movement | 2 | 2018 | 863 | 0.050 |
Why?
| Protein Structure, Quaternary | 1 | 2001 | 115 | 0.050 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2001 | 73 | 0.050 |
Why?
| Surface Tension | 1 | 2000 | 8 | 0.050 |
Why?
| Mannitol | 1 | 2000 | 32 | 0.040 |
Why?
| Isoenzymes | 1 | 2001 | 283 | 0.040 |
Why?
| Protein Subunits | 1 | 2001 | 200 | 0.040 |
Why?
| Muscles | 1 | 2001 | 320 | 0.040 |
Why?
| Cold Temperature | 1 | 2020 | 125 | 0.040 |
Why?
| RNA Stability | 1 | 2020 | 90 | 0.040 |
Why?
| Models, Molecular | 1 | 2004 | 1368 | 0.040 |
Why?
| Biomechanical Phenomena | 1 | 2002 | 669 | 0.040 |
Why?
| Enzyme Activation | 1 | 2001 | 771 | 0.040 |
Why?
| Recombinant Proteins | 2 | 2002 | 1228 | 0.040 |
Why?
| Swine | 1 | 2001 | 687 | 0.040 |
Why?
| Cation Exchange Resins | 1 | 1998 | 7 | 0.040 |
Why?
| Povidone | 1 | 1996 | 5 | 0.030 |
Why?
| Unfolded Protein Response | 1 | 2016 | 44 | 0.030 |
Why?
| Serum Albumin, Bovine | 1 | 1996 | 60 | 0.030 |
Why?
| Myocardium | 1 | 2001 | 911 | 0.030 |
Why?
| Protein Array Analysis | 1 | 2015 | 55 | 0.030 |
Why?
| Cells, Cultured | 2 | 2015 | 3861 | 0.030 |
Why?
| Kidney | 1 | 2021 | 1182 | 0.030 |
Why?
| Protein Conformation | 1 | 1996 | 803 | 0.030 |
Why?
| RNA, Messenger | 1 | 2020 | 2550 | 0.030 |
Why?
| Interferon-alpha | 1 | 2014 | 185 | 0.030 |
Why?
| Mass Spectrometry | 1 | 2016 | 622 | 0.030 |
Why?
| Rats, Sprague-Dawley | 2 | 2008 | 2182 | 0.030 |
Why?
| Glucose | 1 | 1997 | 899 | 0.030 |
Why?
| Hepatocyte Nuclear Factor 4 | 1 | 2012 | 13 | 0.030 |
Why?
| Spectroscopy, Fourier Transform Infrared | 2 | 2003 | 76 | 0.020 |
Why?
| Complement Activation | 1 | 2014 | 337 | 0.020 |
Why?
| Phenotype | 1 | 2018 | 2784 | 0.020 |
Why?
| Rats | 2 | 2008 | 4913 | 0.020 |
Why?
| 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2008 | 6 | 0.020 |
Why?
| Injections, Intraventricular | 1 | 2008 | 71 | 0.020 |
Why?
| Neurotoxicity Syndromes | 1 | 2008 | 14 | 0.020 |
Why?
| beta-Cyclodextrins | 1 | 2008 | 28 | 0.020 |
Why?
| Maze Learning | 1 | 2008 | 87 | 0.020 |
Why?
| Mice, Inbred DBA | 1 | 2008 | 174 | 0.020 |
Why?
| Reflex, Startle | 1 | 2008 | 57 | 0.020 |
Why?
| Exploratory Behavior | 1 | 2008 | 82 | 0.020 |
Why?
| Schizophrenic Psychology | 1 | 2008 | 86 | 0.020 |
Why?
| Drug Design | 1 | 2008 | 147 | 0.020 |
Why?
| Evoked Potentials, Auditory | 1 | 2008 | 167 | 0.020 |
Why?
| Iodides | 1 | 2006 | 6 | 0.020 |
Why?
| Acoustic Stimulation | 1 | 2008 | 306 | 0.020 |
Why?
| Genetic Techniques | 1 | 2006 | 57 | 0.020 |
Why?
| Lipopolysaccharides | 1 | 2008 | 813 | 0.010 |
Why?
| Male | 3 | 2021 | 55396 | 0.010 |
Why?
| NF-kappa B | 1 | 2008 | 636 | 0.010 |
Why?
| Administration, Inhalation | 1 | 2006 | 637 | 0.010 |
Why?
| Hippocampus | 1 | 2008 | 690 | 0.010 |
Why?
| Desiccation | 1 | 2003 | 17 | 0.010 |
Why?
| Signal Transduction | 1 | 2015 | 4501 | 0.010 |
Why?
| Ammonium Sulfate | 1 | 2002 | 12 | 0.010 |
Why?
| Protein Denaturation | 1 | 2002 | 68 | 0.010 |
Why?
| Crystallization | 1 | 2002 | 136 | 0.010 |
Why?
| Protein Structure, Secondary | 1 | 2003 | 325 | 0.010 |
Why?
| Glycerophospholipids | 1 | 2000 | 26 | 0.010 |
Why?
| Vibration | 1 | 2000 | 58 | 0.010 |
Why?
| Colloids | 1 | 2000 | 56 | 0.010 |
Why?
| Lipid Metabolism | 1 | 2003 | 441 | 0.010 |
Why?
| Interferon-gamma | 1 | 2002 | 719 | 0.010 |
Why?
|
|
Anchordoquy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|